Moreover, in the study, we investigated the changes in the Th2 cytokine profile–IL-4 (increased production in allergic reactions) and IL-6 (increased production in inflammatory reactions) in order to assess the influence of HBOT on the severity of inflammation in patients with AD. This evidence concerns the gene IL4 and allergic disease.